In line with Zealand Pharma CEO Adam Steensberg, Novo Nordisk’s cagrisema examine validates the corporate’s potential place within the weight-loss market.
发布者：BY CHRISTOPHER DUE KARLSSON，转转请注明出处：https://robotalks.cn/zealand-sees-disappointing-novo-study-as-advantage-most-patients-are-not-looking-for-the-biggest-weight-loss/
ADNOC and 44.01 are scaling up their Fujairah task to transform 300+ tonnes of carbon monoxide ₂ right into rock .
As the EU’s AI Act prepares to find right into pressure tomorrow, market professionals are evaluating in on its possible effect, highlighting its function in structure count …
Rocketfarm is combining its palletizing software program with Doosan Robotics’ cobots to enhance ease of use and effectivity. The publish Rocketfarm partners to pair palletiz…
The Lego Team has actually included a brand-new local circulation centre (DC) in Tessenderlo, Belgium. According to the Danish plaything maker, the brand-new DC supplies much more …
Diversified miner South32 on Tuesday introduced the visit of 2 brand-new independent non-executive supervisors, Stephen Pearce and Mandlesilo (Mandla) Msimang, to its board. Both a…
